pulmatrix.com (PULM): Net earnings per share growth forecast for next year
Patent protection for the iSPERSE platform and stringent FDA regulations create a robust barrier to entry for competitors. The current EPS growth forecast for the next period on the GURU.Markets chart reflects a trend where the value 0.00 captures the latest metrics. Pulmatrix, Inc. (PULM) is developing B2B partnerships to combat pulmonary infections, although global conflicts and logistical disruptions are complicating the execution of international trials.
Comprehensive metric breakdowns and analytics for pulmatrix.com (PULM)
- share price and consensus valuation forecast:
- stock exchange capitalization data:
- company book value details:
- company total debt and liquidity indicators:
- net income and valuation ratios data:
PULM - Final Profit|Projected Future Earnings Pulmatrix, Inc.|PULM - Business Payback Period|Projected Price to Earnings Pulmatrix, Inc.|PULM - Growth-Adjusted P/E Ratio|Enterprise Value to EBITDA Ratio Pulmatrix|PULM - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) Pulmatrix|PULM - Net earnings per share for the last four quarters|Year-over-year earnings per share growth for the last twelve months pulmatrix.com|PULM - Earnings per share growth this year|Earnings growth forecast for next year Pulmatrix, Inc.
Comprehensive company analysis:Pulmatrix Corp, PULM
The high scalability of Pulmatrix, Inc. (PULM) inhalation technologies creates potential for a sharp reduction in costs during global product deployment. This metric measures expert consensus expectations for net income changes, reflecting the valuation's sensitivity to future cash flows. By analyzing the forward earnings per share (EPS) growth forecast, investors can discern the balance between institutional demand and market skepticism, which serves as a caution against overpaying for the asset.
Main competitors
HLN (Haleon Group) - Earnings growth forecast for next year|Expected net earnings per share growth next year Kenvue Health KVUE|Net earnings per share growth forecast for next year Verona Pharma plc (VRNA)|MENS (jyongbio.com) - Expected earnings per share trend next year|Net earnings per share growth forecast for next year Ligand LGND|AMRX (Amneal Pharmaceuticals, Inc.) - Net earnings per share change forecast for next year|PRGO: Expected earnings per share growth for next year|ALVO - Earnings growth forecast for next year|Liquidia Corporation (LQDA) - Net earnings per share growth forecast for next year|GLPG (glpg.com) - Net earnings per share growth forecast for next year|Net earnings per share growth forecast for next year ANI Pharmaceuticals, Inc.|Expected earnings per share growth for next year MannKind Corp (MNKD)|Earnings growth forecast for next year AMPH|Earnings growth forecast for next year Pacira Corp (PCRX)|ARS Pharmaceuticals - Expected earnings per share growth for next year|Projected earnings per share increase next year TBPH (theravance.com)|AQST - Net earnings per share growth forecast for next year|Expected earnings per share trend next year SCPH (scPharmaceuticals Inc.)|TECX: Earnings growth forecast for next year|TNXP - Consensus forecast of earnings per share growth for next year|Expected earnings per share growth for next year SXTC|Projected earnings per share growth rate for next year EPRX (Eupraxia Pharma)|Expected earnings per share growth for next year BHST (BioHarvest Sciences Inc.)|EXOZ (Invizyne Technologies) - Expected earnings per share trend next year|Earnings growth forecast for next year ORMP (Oramed Pharmaceuticals Inc.)|Consensus forecast of earnings per share growth for next year Entera Bio Ltd (ENTX)|HYFT - Net earnings per share growth forecast for next year|ABVC (abvcpharma.com) - Projected earnings per share growth rate for next year|CPIX: Earnings growth forecast for next year|Expected earnings per share growth for next year Quantum BioPharma Ltd.|Expected earnings per share growth for next year FGEN|Telomir Pharmaceuticals Corp (TELO) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Rani Therapeutics (RANI)|SNYR: Net earnings per share change forecast for next year|Rallybio - Expected earnings per share growth for next year|Earnings growth forecast for next year Lexaria Bioscience Corp LEXX|PTHL - Net earnings per share growth forecast for next year|APM: Net earnings per share growth forecast for next year|Lyra Therapeutics, Inc. (LYRA) - Net earnings per share growth forecast for next year|Expected earnings per share growth for next year Impact BioMedical, Inc.|Net earnings per share growth forecast for next year TNF Pharmaceuticals Inc.|cbdMD Corp - Net earnings per share change forecast for next year|Earnings growth forecast for next year PRFX|CYTO (altamiratherapeutics.com) - Expected earnings per share trend next year|Earnings growth forecast for next year LIPO (Lipella Pharmaceuticals)|Earnings growth forecast for next year optinose.com OPTN|PIRS - Net earnings per share growth forecast for next year|Expected earnings per share trend next year PROC (Procaps Group)|Petros (PTPI) - Net earnings per share growth forecast for next year|Expected earnings per share growth for next year Qilian International Corp|SLRN (Acelyrin, Inc.) - Earnings growth forecast for next year|Earnings growth forecast for next year tffpharma.com
